Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mark; I go there when I am tired of seafood,lol. I like their chicken finger plate. So they let you out Friday night,huh?
Great benz, thanks and looking forward to Monday when I will be free to monitor SLJB (greater) news.
Anyone know why SLJB jumped so much yesterday? I came in from patio building, saw the jump, went to SLJB board and 1000+ new posts. Did not have time to go through them. Did not see any new news. TIA.
From Clark Howard.com:
Ameriprise and Prudential under the scope
Clark gets very upset when innocent, hard-working people save money for their futures, only to see it sifted off by huge financial companies. Back-to-back stories were published today regarding this kind of thing happening at Prudential and at a former division of American Express, known as Ameriprise. In the case of Prudential, the company has pled guilty to criminal charges for helping key insiders do what’s called “after-market trading” in their mutual funds. Basically, it allowed preferred customers to scarf up all the profits while money was taken away from regular customers. The company is now paying $600 million to avoid criminal prosecution. With Ameriprise, the former financial advisor for American Express, one of the top brokers wiped out tons of bank accounts by putting people in bad accounts. The broker focused most of his energy on retirees from Exxon, who had large retirement accounts. American Express is trying to distance itself from the news and will not be penalized. But it is clear the two were affiliated. Granted, many commissioned financial salespeople are above board. But if you trust a commissioned salesperson with your money and something goes wrong, you are out of luck. Low or no-commission accounts are the smartest way to save. Get more info with Clark’s Investment Guide.
Thanks Stock H.O.G.-a membermark for you.
Ignore my previous message-answer is here and I feel more confident. Thanks to H.O.G.
Posted by: Stock H.O.G.
In reply to: None Date:9/11/2006 5:12:18 PM
Post #of 69401
Q & A with Marquee:
I spoke with Chad from Marquee today for about 30 minutes. Below you will find the Q&A details. I did my best to capture the questions and concerns of the board.
1) Are the audited financials still slated to come out mid-Sept? Yes, they should be out at the latest, next week. However, they could be any day now.
2) Which fiscal year-end will Sulja use in the U.S.? Not sure, but that will be clear when the audited financials come out.
3) With the change in the CEO, can you confirm that there is no plan to change the current share structure? No change was mentioned to him.
4) Can you confirm that the client we lost is not the cement deal (i.e. Ramada)? The cement deal was not lost, but the client (Ramada General Contracting) was not happy with all of the calls (also note they are a private company and not used to shareholders hounding them for information). Bottom line, we have the cement deal still.
5) Has Wessal started buying their 25%? If not why would they wait? Is there an advantage for them to wait? Not sure if they started buying. Note, Wessal has big money and are not concerned with the PPS going up somewhat before they start buying.
6) Any ETA on the move to the OTCBB? Most likely very soon after the audited financials. It should be quick.
7) Can you explain why Shahid Khan was named the CEO for one day? Basically, the plan was for Petar to take this position eventually, so Khan was in there as a temporary. After they put him in the position, Petar decided it might be best for him to take over now, instead of later. Basically a whoops, maybe Petar needs to be in control, given all of the complexities.
8) Are you considering dividends, as this may get the attention of some big buyers (i.e. hedge funds). It's not out of the question and they expect retail buying after the audited financials come out.
9) Do you know of any naked short or regular short selling? If so, do you know what the numbers are? Also, what are the plans to counter such activity? Yes, there is shorting taking place, but it's impossible to track the numbers because much of it is done via Canada. A guess would be 200-300 million. After the audited financials, retail buying will begin and shorts will have to cover (i.e. margin call!!), that's how the company will counter.
10) Do you know how many shares above and beyond the current O/S LWFK owned? Did they control more shares than what was in the float? Were they required to sell the shares back into the public float, as to not have a negative float? Word has it that they (LWFK) own no shares and Dennis was completely bought-out. The share structure is the same as recently PR'd.
11) If the goal is to get to the NASDAQ and we must maintain a $4 PPS for an extended period, does the company believe their financial results alone will get us above $4 or is there something else in mind? Audited numbers, major growth, and retail buying will get us there.
12) It was stated that Steve Sulja would stay on as a consultant. Can you expand on what his new role might look like? (i.e. board of directors, etc.). Exact role not known, but basically the big guys are taking over.
13) Can you provide any information regarding a reverse merger with Consultech? There are no mergers in the works at this time.
14) On the Sulja website, there are no numbers posted for June and July, 2006, can you explain and can we get these numbers? He's going to look into this.
15) fyi...on Ameritrade, Sulja is listed as Suija. Can you look into having this revised? He will let someone know and work to have this fixed.
Other Notes:
1) Petar has been in control and the main man for a while now. He has the experience we need to run the company, which is beginning to become more complex (i.e. international and public). He's very good at negotiating and closing deals and is a straight shooter. You should feel very good about him being there.
2) Marquee Asset Mgmt does not release PRs, they are done by Petar. MAM does, however, advise Petar on what they believe should be released, hence the vast number of recent PRs.
Hey all-was the SLJB cement contract cancelled? I,ve read different opinions on it. TIA.
que-I have noticed the name "bruzz/bruzzone" mentioned a few times. Who/what is she/it? I do not fol;low yahoo board. TIA.
brent, great post as usual. Hope you sent a copy to Marquee.
I have a suggestion; get off that caffeinated iced tea and go to decaf-you are staying up too late :)
Steve Sulja, Outgoing CEO of Sulja Bros. Building Supplies Ltd., Announces Decision to Step Down in Favour of New CEO
WINDSOR, ON -- (MARKET WIRE) -- September 07, 2006 -- Sulja Bros. Building Supplies Ltd. (PINKSHEETS: SLJB) outgoing CEO welcomes the appointment of new CEO.
Former CEO Steve Sulja, in context to new developments with SLJB, stated today, "I would like to take this opportunity to congratulate Petar Vucicevich as the new CEO of Sulja Bros. Building Supplies Ltd. My decision to resign was made after long deliberations with all members of the Sulja board. I feel that Mr. Vucicevich will better serve the direction of this corporation in its international growth. His experience in dealing with companies internationally will surely benefit Sulja Bros. Mr. Vucicevich asked me to stay behind as a consultant during this time and I will gladly accept this position. Mr. Vucicevich has the support of the entire Sulja organization here and abroad, and I ask all shareholders, members of the board and management and clients to show Mr. Vucicevich the same support you had extended to me in the past. I expect great things for Sulja and plan to work closely with Mr. Vucicevich. I believe all shareholders will be pleased with Mr. Vucicevich's professionalism and no nonsense approach. I thank you all again for all your support and wish everyone the best."
A spokesperson on behalf of Sulja Bros. stated, "We support Steve's decision to resign in favour of Mr. Vucicevich and look forward to working closely with him in his new capacity."
This contains forward-looking information within the meaning of The Private Securities Litigation Act of 1995. Forward-looking statements may be identified through the use of words such as "expects," "will," "anticipates," "estimates," "believes," or statements indicating certain actions: "may," "could," "should" or "might occur." Such forward-looking statements involve certain risks and uncertainties. The actual result may differ materially from such forward-looking statements. The company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results (expressed or implied) will not be realized.
--------------------------------------------------------------------------------
SOURCE: Sulja Bros. Building Supplies Ltd.
"Economic freedom Fund" seems to be a group of liars according to TV report.
Truth Test: Hidden Republicans Attack Marshall
--------------------------------------------------------------------------------
Web Editor: Rich Hardwick
Originally Created: 9/7/2006 7:54:49 PM
Last Update: 9/7/2006 8:13:50 PM
Click Here to Watch From Sept. 7, 2006 - 6 p.m.
Printable Version
Political campaign season really cranks up after Labor Day in most election years. That's when candidates and party supporters begin bombarding voters with campaign ads. This year won't be an exception.
A few days ago, a California organization attacked U.S. Rep. Jim Marshall, a Macon Democrat, in an ad that attempts to embed Marshall with Ted Kennedy, Hillary Clinton and Nancy Pelosi. The ad also tosses in U.S. Rep. Cynthia McKinney, a Georgia Democrat who lost her re-election bid this year after having a run in with Capitol police in Washington.
Marshall faces Mac Collins, a Jackson Republican, in the Nov. 7 general election. They're vying for Georgia's 8th District congressional seat. The General Assembly redrew the district this year, making it more Republican friendly. Marshall is listed as the incumbent in the newly draw territory.
The attack ad says it's paid for by the Economic Freedom Fund, a 527 organization. On its website, fund organizers say its purpose is to educate people concerning economic freedom and growth and to help bring prosperity to the American people.
Located in Sacramento, Ca., the Economic Freedom Fund office is located in the law firm of Bell, McAndrews and Hiltachk. Attorney Charles H. Bell Jr. serves as senior partner of the firm. Bell also serves as general counsel of the California Republican Party, and he's the Republican National Lawyers Association's vice president for the election education advisory council.
His other duties include being spokesman for the Economic Freedom Fund.
Bell wasn't available to take a call Wednesday to answer questions about the fund's involvement in Jim Marshall's campaign. He still hasn't returned the call.
Among other thing, Economic Freedom brings U.S. Sen. Ted Kennedy into the ad by asking if Kennedy was the person who voted to keep letting trial lawyers sue little leagues for bruises during a came.
It questions whether U.S. Sen. Hillary Clinton repeatedly voted to keep the so-called death tax, and it questions whether Cynthia McKinney voted to make U.S. Rep. Nancy Pelosi speaker of the House.
The ad says it wasn't those three who cast those votes. It identified the voter as Jim Marshall before asking, "Who is he representing?" The ad failed the 13WMAZ Truth Test because it misrepresented Marshall's position.
It's unlawful for 527 organizations like Economic Freedom Fund to coordinate their activities with candidates and their ads. But at the same time the Economic Freedom Fund is running the attack ad against Jim Marshall, Mac Collins is running a campaign ad touting his support for complete elimination of the death tax.
Perhaps we should invest in this FDA approved virus???
Posted by: mypointz
In reply to: None Date:9/6/2006 7:17:18 PM
Post #of 1840
Is thsi good or bad..............certainly FDA is getting more innovative!!!!????
The FDA Approves Viral Adulteration of Our Food Supply
August 24, 2006
On Friday, August 18, 2006, the FDA approved a viral cocktail to be sprayed on foods we eat. This is the first time viruses have been approved for use as food additives. The FDA wants you to believe it will be safe to consume these viruses every day for the rest of your life with no adverse health effects. This is a monumental announcement by the FDA, indicating they are throwing all caution to the wind regarding the safety of our food supply.
Are you willing to stand in line for a virus-laden sandwich? How do you like the idea of buying virus-infested food for your family? The first virally contaminated foods entering our food supply with the blessings of the FDA will be luncheon meat and poultry. Live viruses will be sprayed on foods such as cold cuts, sausages, hot dogs, sliced turkey, and chicken.
At issue is the very real problem of a poor quality FDA-approved food supply that is already full of diseased and sickly animals, many of them imported from other countries. The use of antibiotics during growth and radiation during food processing is required by the fast-food animal farms owned by multi-national companies to cover up the horrendous health of the animals they wish to feed to Americans. Animals in poor health are a friendly place for bacteria to grow and prosper, especially after such meat goes to market. Rather than address the source of the problem, the FDA wants to add another adulteration into our food supply.
The stated goal of the new FDA-approved viruses is to kill a rare bacterium known as Listeria monocytogenes. This bacterium is killed by cooking; however, it poses a problem in meats that are cooked during processing and not cooked again prior to consumption, so it can readily infect foods such as deli meats.
Yes, the FDA plans to use one infectious organism to fight another. The carnage of battle will end up in your digestive tract along with the victorious live viruses, which the FDA assures us will not attack human cells. However, they cannot possibly be certain the viruses will not attack the friendly bacteria that make up the lining of your digestive tract. The FDA approval was based on scant human testing, mostly from unrelated medical experiments. Such safety data is woefully inadequate to determine safe ingestion of a specific product by humans over the course of a lifetime.
Turning Loose the Bacteria-Killing Viruses
The company that produces these biotech viruses is Baltimore-based Intralytix, Inc. The viruses are known as bacteriophages, viruses that kill bacteria, or phages for short. Phages have been around a long time, living as parasites inside many bacteria.
Intralytix uses biotechnology to grow viral phages in a culture with Listeria, in theory teaching the viruses to recognize the bacteria. The FDA-approved cocktail contains six different viruses intended to attack one strain of bacteria.
This concoction is then sprayed on food. If Listeria is present in the food, the bacteria will ingest the viruses. This results in massive viral replication inside the bacteria, until such point as the bacteria simply bursts. This battle results in significant production of bacterial poisons called “endotoxins”, as the bacteria tries to defend itself. When the bacteria burst, these endotoxins are released. These, along with the victorious live viruses, will now be on the food that will be eaten.
The FDA and Intralytix would like us to believe that these viruses will only attack the specified bacteria they are intended to kill and will be harmless to humans. I’m sorry to burst their bubble, but they can’t possibly guarantee such safety. It is true that the viruses, at least at this time, cannot recognize human cells. However, the virus can potentially recognize normal bacterial cells in the human digestive tract and may be able to adapt to infect one or more of these friendly bacteria.
The FDA Certainly Knows There Are Risks
The FDA had some concerns about the amount of bacterial endotoxin in the Intralytix product before it is sprayed; however, FDA tests apparently showed that the product was adequately purified and so they declared it safe if used as approved. Will the FDA diligently monitor the quality of this product once it is on the market, or will it go the path of many FDA-approved drugs that the agency can’t keep track of?
There is certainly a risk that humans will be exposed to excessive amounts of endotoxin. This could come from the manufacturing of the viral cocktail, the interaction of the viruses with bacteria after being sprayed on food, and/or the interaction of the viruses with bacteria in the digestive tract.
The human immune system is highly reactive and sensitive to bacterial endotoxins. They provoke allergy, asthma, autoimmune problems, and elevate cholesterol. They also interfere with the healthy function of cells lining the digestive tract. Researchers have demonstrated that the presence of bacterial endotoxins can start cancer in the colon.
Additionally, the human immune system reacts directly to viral phages. Thus, a person who eats a lot of processed deli meat is certain to evoke an immune reaction to the viruses. What will this reaction be? Allergy? Asthma? Autoimmunity? Cancer? How can the FDA approve a food additive that it knows can induce a variety of human immune responses? Phages are so good at disrupting normal immunity that they are being considered for use as part of organ transplant medicine.
The ingestion of significant amounts of viral phages into the human digestive tract is a wild card full of unknown outcomes. For example, it is certainly possible that these phages, which constantly mutate in order to survive, are likely to find a way to infect bacteria they were not intended to infect. Since phages are parasites, they could hijack the friendly bacteria of the digestive tract and turn them into viral machines, constantly generating viral particles that are likely to confuse the human immune system, if not directly infect the body. We know from history that these viral phages can turn innocuous bacteria into a killer, which is how cholera occurs.
Furthermore, the Listeria bacteria are not going to take the issue lying down. They will develop resistance to the viruses over time, as we have seen with the overuse of antibiotics. Going down this path we are likely to have hundreds of viral food additives in the food we eat, all designed to combat some possible infection coming from poor quality food. Sooner or later we will inadvertently create deadly new super-strains of bacteria and/or parasitically infect the human digestive tract with an untreatable infection.
There is also the very real possibility of unintended viral recombination. What happens when a person with viral stomach flu eats food containing a dose of this viral food additive? It is certainly possible for the genetic material of the flu virus to interact with the genetic material of the viral phages, provoking an undesirable new viral infection.
Let’s not forget that the FDA won’t tell us which foods in the food supply contain genetically modified organisms (GMO). Seventy percent of the packaged food on grocery shelves already contains GMO adulterated food. These foods have viral promoter genes woven into the DNA of every cell, a technique used to implant a pesticide toxin into every cell of this fake food (see Fight for Your Health, chapter 15). What happens when the viral phages interact with the viral promoter genes in GMO food? What new virus will be encouraged to form?
Keep in mind that the FDA wants to conduct this experiment on our food supply to protect a small minority, only about 2500 people, who are made seriously ill by this infection each year. The ill are mostly pregnant women, elderly with compromised immunity, and small children. It would be a lot more to the point if the FDA would simply warn such people that eating these foods, due to their poor quality of production, may be dangerous. What the FDA should really do is improve the quality of our food supply, the true source of the problem. Why expose millions of Americans to an unproven ingestion of live viruses for the benefit of so few?
The FDA has failed miserably for the past century to protect the public from the adulteration of our food supply by vested interests. This is just one more insult added to a long list of injuries.
The Tip of an Iceberg
Intralytix has an agenda for the American food supply, as well as for healthcare in general. This recent FDA ruling allows Intralytix and other similar biotech companies to get their foot in a door that should be slammed shut and bolted closed.
The company is also seeking FDA approval for viral sprays to treat foods that could be contaminated with E. coli and Salmonella, which means that similar “trained” viruses could end up in a majority of the protein foods in our food supply.
Intralytix sees financial opportunity. They have already licensed their now FDA-approved viral spray to an undisclosed multi-national company for use around the world.
When the CEO of Intralytix, John Vazzara, was recently asked about this partner company, he refused to disclose their name. The grand profit-driven biotech experiment on the health and well being of all Americans is now in full swing.
John Vazzara also owns stock in, as well as provided seed money to start, SteelCloud Inc. (formerly Dunn Computer Corporation). SteelCloud is a defense contractor with lucrative deals with the Department of Defense, recently landing a 3.4 million dollar contract with the Department of Homeland Security.
Congress should investigate the financial ties and backroom dealings that would allow this bizarre food additive approval by the FDA.
Of course, we will need new wonder drugs to combat the new bio-tech produced infections. Americans will stay sick and the sickness-driven bio-tech industry will flourish. The bio-tech industry will make people sick on the front end and treat them on the back end. It’s a win-win situation for profit on illness.
The FDA is Rapidly Becoming a Public Enemy
Experimenting with viruses being added to the food supply is incredibly dangerous and reckless. It is completely impossible for the FDA to guarantee safety in the near term or the long term. Thus, the FDA has made the bureaucratic decision that relative safety is acceptable to them. What right does the FDA have to tamper with the food supply in this manner?
It is quite clear that the Bush agenda has been to promote American biotech companies as the new future for American prosperity. Administrative opinions have trumped science in virtually every situation wherein safety conflicts with profit. The FDA acts to foster profits for biotech companies and the growth of the biotech industry. This is a betrayal of the public trust.
The leaders of the FDA are personally responsible and need to be held accountable. This means Andrew von Eschenbach, M.D., temporary head of the FDA and his chief science officer, Scott Gottlieb, M.D. These men are not only obsessed with approving risky drugs for the benefits of Big Pharma, it is now clear that they are willing to allow obvious adulteration of the food supply. They seek to control what we eat, and they are tampering with survival of the human race.
The FDA does not truly know how safe viral phages are to consume on a regular basis. They have no idea of the cumulative effect over the course of a lifetime, especially as more of these viral cocktails are added to the food supply. They have no way to measure how this new type of adulteration in the food supply will interact with the poor digestive/immune health of half the American population, in combination with all the other serious adulterations already approved by the FDA. The FDA lacks due diligence in honoring its mandate to protect the American public.
Boycott Viral Tainted Foods, Support Your Sustainable Farmers
The only hope Americans have is to resurrect the quality of our food supply. Doing so is against the odds, as there are billions of dollars of profit-mongering taking our food supply in the wrong direction. One day Americans will realize that food security is as important to national security as any other topic. It is now crystal clear that we cannot count on the FDA to do the job that Harvey Wiley, M.D., envisioned one-hundred years ago.
Consumers standing in line to buy a luncheon meat sandwich will have no idea if they are ingesting live viruses as part of their meal. While the FDA will require the ingredient to be listed on packages as “bacteriophage preparation,” most consumers will have no idea that means they are ingesting live viruses. Foods bought at deli counters or prepared in restaurants will not need to warn consumers.
How can any responsible parent feed virus-tainted food to their children? The FDA should be forced to revoke this approval. Every American has an obligation to support food security for our nation. Congress must correct the leadership at the FDA and the FDA itself. Americans must quit buying poor quality toxic food. Your greatest ability to change this problem is based entirely on what you purchase.
Get connected to the sustainable family farms in your community. Buy meat that is range raised without antibiotics and synthetic growth hormones. Demand that the food you are eating is labeled with a country of origin. Buy American; buy locally-produced food whenever possible. Support those who truly believe in being the stewards of our land and food for our people and for future generations. These good people are being squashed out of existence by multi-national agribusiness, companies that could truly care less about the quality of our food supply or the security and health of Americans. How you spend your money is your most powerful vote. Vote for those who care.
http://www.truthinwellness.com/articles/viral_food.htm
Posted by: mypointz
In reply to: None Date:9/6/2006 7:17:18 PM
Post #of 1840
Is thsi good or bad..............certainly FDA is getting more innovative!!!!????
The FDA Approves Viral Adulteration of Our Food Supply
August 24, 2006
On Friday, August 18, 2006, the FDA approved a viral cocktail to be sprayed on foods we eat. This is the first time viruses have been approved for use as food additives. The FDA wants you to believe it will be safe to consume these viruses every day for the rest of your life with no adverse health effects. This is a monumental announcement by the FDA, indicating they are throwing all caution to the wind regarding the safety of our food supply.
Are you willing to stand in line for a virus-laden sandwich? How do you like the idea of buying virus-infested food for your family? The first virally contaminated foods entering our food supply with the blessings of the FDA will be luncheon meat and poultry. Live viruses will be sprayed on foods such as cold cuts, sausages, hot dogs, sliced turkey, and chicken.
At issue is the very real problem of a poor quality FDA-approved food supply that is already full of diseased and sickly animals, many of them imported from other countries. The use of antibiotics during growth and radiation during food processing is required by the fast-food animal farms owned by multi-national companies to cover up the horrendous health of the animals they wish to feed to Americans. Animals in poor health are a friendly place for bacteria to grow and prosper, especially after such meat goes to market. Rather than address the source of the problem, the FDA wants to add another adulteration into our food supply.
The stated goal of the new FDA-approved viruses is to kill a rare bacterium known as Listeria monocytogenes. This bacterium is killed by cooking; however, it poses a problem in meats that are cooked during processing and not cooked again prior to consumption, so it can readily infect foods such as deli meats.
Yes, the FDA plans to use one infectious organism to fight another. The carnage of battle will end up in your digestive tract along with the victorious live viruses, which the FDA assures us will not attack human cells. However, they cannot possibly be certain the viruses will not attack the friendly bacteria that make up the lining of your digestive tract. The FDA approval was based on scant human testing, mostly from unrelated medical experiments. Such safety data is woefully inadequate to determine safe ingestion of a specific product by humans over the course of a lifetime.
Turning Loose the Bacteria-Killing Viruses
The company that produces these biotech viruses is Baltimore-based Intralytix, Inc. The viruses are known as bacteriophages, viruses that kill bacteria, or phages for short. Phages have been around a long time, living as parasites inside many bacteria.
Intralytix uses biotechnology to grow viral phages in a culture with Listeria, in theory teaching the viruses to recognize the bacteria. The FDA-approved cocktail contains six different viruses intended to attack one strain of bacteria.
This concoction is then sprayed on food. If Listeria is present in the food, the bacteria will ingest the viruses. This results in massive viral replication inside the bacteria, until such point as the bacteria simply bursts. This battle results in significant production of bacterial poisons called “endotoxins”, as the bacteria tries to defend itself. When the bacteria burst, these endotoxins are released. These, along with the victorious live viruses, will now be on the food that will be eaten.
The FDA and Intralytix would like us to believe that these viruses will only attack the specified bacteria they are intended to kill and will be harmless to humans. I’m sorry to burst their bubble, but they can’t possibly guarantee such safety. It is true that the viruses, at least at this time, cannot recognize human cells. However, the virus can potentially recognize normal bacterial cells in the human digestive tract and may be able to adapt to infect one or more of these friendly bacteria.
The FDA Certainly Knows There Are Risks
The FDA had some concerns about the amount of bacterial endotoxin in the Intralytix product before it is sprayed; however, FDA tests apparently showed that the product was adequately purified and so they declared it safe if used as approved. Will the FDA diligently monitor the quality of this product once it is on the market, or will it go the path of many FDA-approved drugs that the agency can’t keep track of?
There is certainly a risk that humans will be exposed to excessive amounts of endotoxin. This could come from the manufacturing of the viral cocktail, the interaction of the viruses with bacteria after being sprayed on food, and/or the interaction of the viruses with bacteria in the digestive tract.
The human immune system is highly reactive and sensitive to bacterial endotoxins. They provoke allergy, asthma, autoimmune problems, and elevate cholesterol. They also interfere with the healthy function of cells lining the digestive tract. Researchers have demonstrated that the presence of bacterial endotoxins can start cancer in the colon.
Additionally, the human immune system reacts directly to viral phages. Thus, a person who eats a lot of processed deli meat is certain to evoke an immune reaction to the viruses. What will this reaction be? Allergy? Asthma? Autoimmunity? Cancer? How can the FDA approve a food additive that it knows can induce a variety of human immune responses? Phages are so good at disrupting normal immunity that they are being considered for use as part of organ transplant medicine.
The ingestion of significant amounts of viral phages into the human digestive tract is a wild card full of unknown outcomes. For example, it is certainly possible that these phages, which constantly mutate in order to survive, are likely to find a way to infect bacteria they were not intended to infect. Since phages are parasites, they could hijack the friendly bacteria of the digestive tract and turn them into viral machines, constantly generating viral particles that are likely to confuse the human immune system, if not directly infect the body. We know from history that these viral phages can turn innocuous bacteria into a killer, which is how cholera occurs.
Furthermore, the Listeria bacteria are not going to take the issue lying down. They will develop resistance to the viruses over time, as we have seen with the overuse of antibiotics. Going down this path we are likely to have hundreds of viral food additives in the food we eat, all designed to combat some possible infection coming from poor quality food. Sooner or later we will inadvertently create deadly new super-strains of bacteria and/or parasitically infect the human digestive tract with an untreatable infection.
There is also the very real possibility of unintended viral recombination. What happens when a person with viral stomach flu eats food containing a dose of this viral food additive? It is certainly possible for the genetic material of the flu virus to interact with the genetic material of the viral phages, provoking an undesirable new viral infection.
Let’s not forget that the FDA won’t tell us which foods in the food supply contain genetically modified organisms (GMO). Seventy percent of the packaged food on grocery shelves already contains GMO adulterated food. These foods have viral promoter genes woven into the DNA of every cell, a technique used to implant a pesticide toxin into every cell of this fake food (see Fight for Your Health, chapter 15). What happens when the viral phages interact with the viral promoter genes in GMO food? What new virus will be encouraged to form?
Keep in mind that the FDA wants to conduct this experiment on our food supply to protect a small minority, only about 2500 people, who are made seriously ill by this infection each year. The ill are mostly pregnant women, elderly with compromised immunity, and small children. It would be a lot more to the point if the FDA would simply warn such people that eating these foods, due to their poor quality of production, may be dangerous. What the FDA should really do is improve the quality of our food supply, the true source of the problem. Why expose millions of Americans to an unproven ingestion of live viruses for the benefit of so few?
The FDA has failed miserably for the past century to protect the public from the adulteration of our food supply by vested interests. This is just one more insult added to a long list of injuries.
The Tip of an Iceberg
Intralytix has an agenda for the American food supply, as well as for healthcare in general. This recent FDA ruling allows Intralytix and other similar biotech companies to get their foot in a door that should be slammed shut and bolted closed.
The company is also seeking FDA approval for viral sprays to treat foods that could be contaminated with E. coli and Salmonella, which means that similar “trained” viruses could end up in a majority of the protein foods in our food supply.
Intralytix sees financial opportunity. They have already licensed their now FDA-approved viral spray to an undisclosed multi-national company for use around the world.
When the CEO of Intralytix, John Vazzara, was recently asked about this partner company, he refused to disclose their name. The grand profit-driven biotech experiment on the health and well being of all Americans is now in full swing.
John Vazzara also owns stock in, as well as provided seed money to start, SteelCloud Inc. (formerly Dunn Computer Corporation). SteelCloud is a defense contractor with lucrative deals with the Department of Defense, recently landing a 3.4 million dollar contract with the Department of Homeland Security.
Congress should investigate the financial ties and backroom dealings that would allow this bizarre food additive approval by the FDA.
Of course, we will need new wonder drugs to combat the new bio-tech produced infections. Americans will stay sick and the sickness-driven bio-tech industry will flourish. The bio-tech industry will make people sick on the front end and treat them on the back end. It’s a win-win situation for profit on illness.
The FDA is Rapidly Becoming a Public Enemy
Experimenting with viruses being added to the food supply is incredibly dangerous and reckless. It is completely impossible for the FDA to guarantee safety in the near term or the long term. Thus, the FDA has made the bureaucratic decision that relative safety is acceptable to them. What right does the FDA have to tamper with the food supply in this manner?
It is quite clear that the Bush agenda has been to promote American biotech companies as the new future for American prosperity. Administrative opinions have trumped science in virtually every situation wherein safety conflicts with profit. The FDA acts to foster profits for biotech companies and the growth of the biotech industry. This is a betrayal of the public trust.
The leaders of the FDA are personally responsible and need to be held accountable. This means Andrew von Eschenbach, M.D., temporary head of the FDA and his chief science officer, Scott Gottlieb, M.D. These men are not only obsessed with approving risky drugs for the benefits of Big Pharma, it is now clear that they are willing to allow obvious adulteration of the food supply. They seek to control what we eat, and they are tampering with survival of the human race.
The FDA does not truly know how safe viral phages are to consume on a regular basis. They have no idea of the cumulative effect over the course of a lifetime, especially as more of these viral cocktails are added to the food supply. They have no way to measure how this new type of adulteration in the food supply will interact with the poor digestive/immune health of half the American population, in combination with all the other serious adulterations already approved by the FDA. The FDA lacks due diligence in honoring its mandate to protect the American public.
Boycott Viral Tainted Foods, Support Your Sustainable Farmers
The only hope Americans have is to resurrect the quality of our food supply. Doing so is against the odds, as there are billions of dollars of profit-mongering taking our food supply in the wrong direction. One day Americans will realize that food security is as important to national security as any other topic. It is now crystal clear that we cannot count on the FDA to do the job that Harvey Wiley, M.D., envisioned one-hundred years ago.
Consumers standing in line to buy a luncheon meat sandwich will have no idea if they are ingesting live viruses as part of their meal. While the FDA will require the ingredient to be listed on packages as “bacteriophage preparation,” most consumers will have no idea that means they are ingesting live viruses. Foods bought at deli counters or prepared in restaurants will not need to warn consumers.
How can any responsible parent feed virus-tainted food to their children? The FDA should be forced to revoke this approval. Every American has an obligation to support food security for our nation. Congress must correct the leadership at the FDA and the FDA itself. Americans must quit buying poor quality toxic food. Your greatest ability to change this problem is based entirely on what you purchase.
Get connected to the sustainable family farms in your community. Buy meat that is range raised without antibiotics and synthetic growth hormones. Demand that the food you are eating is labeled with a country of origin. Buy American; buy locally-produced food whenever possible. Support those who truly believe in being the stewards of our land and food for our people and for future generations. These good people are being squashed out of existence by multi-national agribusiness, companies that could truly care less about the quality of our food supply or the security and health of Americans. How you spend your money is your most powerful vote. Vote for those who care.
http://www.truthinwellness.com/articles/viral_food.htm
Advanced Search
Home
Our Services
Why Use Us?
Recent News
Resources
About Us
For Media
Log In/Submit
Press Release Distribution >
EDGAR Filing
Custom Wire
Easy IR
Easy PR
SEO Enhanced
Webcasting
Conference Calling
News Dashboard
Our Products
Email this Release | Printer-Friendly
--------------------------------------------------------------------------------
Sulja Bros. Announces Prominent Canadian Attorney as New CEO
WINDSOR, ON -- (MARKET WIRE) -- September 06, 2006 -- Sulja Bros. Building Supplies, Ltd. (PINKSHEETS: SLJB) announced today that a new CEO has been hired.
A company spokesperson stated: "We have offered the CEO position to Mr. Shahid Khan, a prominent attorney in Ontario, Canada. With the new CEO on board, the contracts he was involved with will be announced. Mr. Shahid Khan has been functioning as a bridge between our North American suppliers and Middle Eastern Contractors. Mr. Shahid Khan has been the facilitator of many contracts in the Middle East."
This contains forward-looking information within the meaning of The Private Securities Litigation Act of 1995. Forward-looking statements may be identified through the use of words such as "expects," "will," "anticipates," "estimates," "believes," or statements indicating certain actions: "may," "could," "should" or "might occur." Such forward-looking statements involve certain risks and uncertainties. The actual result may differ materially from such forward-looking statements. The company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results (expressed or implied) will not be realized.
--------------------------------------------------------------------------------
SOURCE: Sulja Bros. Building Supplies, Ltd.
Advanced Search
Home
Our Services
Why Use Us?
Recent News
Resources
About Us
For Media
Log In/Submit
Press Release Distribution >
EDGAR Filing
Custom Wire
Easy IR
Easy PR
SEO Enhanced
Webcasting
Conference Calling
News Dashboard
Our Products
Email this Release | Printer-Friendly
--------------------------------------------------------------------------------
Sulja Bros. Announces Prominent Canadian Attorney as New CEO
WINDSOR, ON -- (MARKET WIRE) -- September 06, 2006 -- Sulja Bros. Building Supplies, Ltd. (PINKSHEETS: SLJB) announced today that a new CEO has been hired.
A company spokesperson stated: "We have offered the CEO position to Mr. Shahid Khan, a prominent attorney in Ontario, Canada. With the new CEO on board, the contracts he was involved with will be announced. Mr. Shahid Khan has been functioning as a bridge between our North American suppliers and Middle Eastern Contractors. Mr. Shahid Khan has been the facilitator of many contracts in the Middle East."
This contains forward-looking information within the meaning of The Private Securities Litigation Act of 1995. Forward-looking statements may be identified through the use of words such as "expects," "will," "anticipates," "estimates," "believes," or statements indicating certain actions: "may," "could," "should" or "might occur." Such forward-looking statements involve certain risks and uncertainties. The actual result may differ materially from such forward-looking statements. The company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results (expressed or implied) will not be realized.
--------------------------------------------------------------------------------
SOURCE: Sulja Bros. Building Supplies, Ltd.
Wow brent-you da man, to stay awake at that hour to do great DD for us. Much appreciated by all.
Was that PR you mentioned the news article I posted yesterday morning or did I miss another one (PR)? Thanks again.
Back to my patio project after 6 days of rain.
oreo; has anyone estimated the net on this cement deal? TIA.
hogfan; the mm,s supposedely trade "false" shares sometimes called "air shares" (shares that dont exist) from what I understand. Evidently the SEC allows that and has received lots of flack over it.
I hope someone with better knowledge than I on the subject will explain it to you.
debleg;no-it is a good thing, in fact another poster gave you one after I did. You do not get a gift for it though :)
Well the news made forbes also-
http://www.forbes.com/home/feeds/afx/2006/09/05/afx2993661.html
debelg; I am going to take you at your word and also give you a member mark for your DD (calls). I personally think Parkin probably talked too much and got in a little over his head.
Time will tell.
How about 2create?
From my earlier post on NDOL board-
Posted by: Stockbuilder
In reply to: None Date:9/5/2006 11:11:07 AM
Post #of 16686
Forgot to put in link for news article:
http://www.bbj.hu/main/news_16322_mol+signs+agreement+to+buy+out+partners+stake+in+siberian+oil+fiel....
--if it works.
Forgot to put in link for news article:
http://www.bbj.hu/main/news_16322_mol+signs+agreement+to+buy+out+partners+stake+in+siberian+oil+fiel...
--if it works.
vic, I hope someone can explain it.
antsquires, I don,t have a clue.
FYI
INDUSTRY & MANUFACTURING > Oil & Gas
Mol to buy out partner in Siberian oil field
05 Sep 2006 bbj.hu
Hungarian oil and gas company Mol Nyrt has signed an agreement to buy out a stake in an oil field in Siberia from its partner, Russia's North-West Oil Group (NWOG), NWOG CEO Julija Sozina confirmed on Monday for MTI's Russian correspondent. Mol, which holds 50% of the stake in the oil field, has agreed to buy NWOG's 50% stake by year-end, Sozina said, confirming a report in Russian business daily Kommersant. Seismology measurements started at the Surgutsky-7 field in Siberia's Khantia-Mansia Autonomous District in October 2005, and test drilling is expected to start next year. The field is thought to have potential reserves - C3-category under the Russian system - of 1.9 million tons, and forecast, or D1-category, reserves of 21.4 million tons. Sozina declined to reveal the price Mol would pay for the stake. Kommersant wrote that NWOG paid $11 million for the concession in the spring of 2005, but noted it could be worth double that amount now. (Econews)
Lakedweller, I live in Ga. You all are welcome to move Atlanta over there :)
NYCguy, wishful thinking but makes sense. Why did,nt I think of that,lol. One thing to remember is our schedules are far apart from theirs.
Thanks Brent & rrufff. I think I remember that same thread being repeated before but have not had the time to follow it back. I know the shorts,etc (scammers) have hit the SLJB board but that post looked like it might have something behind it.
My biggest doubt when I first purchased was a terrorist group being behind the stock (that Sulja Bros. had been sucked in) because many of them hide behind "charities". I now think this stock is too much in the public forum for that.
Another question for the board-for those in AURC and NDOL. Do you know the background of 2C? He is very knowledgeable of Russian connected stocks.
I asked him if he was ever connected to the natural resources field and he only posted back a photo of the grinning guy (with gold teeth)holding a gold bar.
I,ve held NDOL since it was CXIN and bought AURC because C2 moderated NDOL board at one time, along with "treepeople" ,who has disappeared supposedly because he is in a business where his views are not allowed on message boards???
Brent,lol. I WAS NOT drinking "long island iced tea" yesterday, nor regular iced tea as the patio is in hot sun. The carpenter and I went through a lot of iced water though.
Ernesto has brought rain to N. Ga. mtn. cabin this morning and I am inside going through message boards. I even went to "Raging zoo" and read some of the SLJB basher reports. If you (or others) have time, look at post # 49172(LFWK) from Soldier of Fortune (copied post from "Fisty")and give us your take on it. Has anyone discredited this info in the past-I think I saw the same post somewhere else a few days ago.
As I said once before, I have sold none of my shares and plan to hold, but there are a couple of things that concern me (as they do with all pinks I own). TIA.
Thanks brent and others for some good posts. I have been at my mountain cabin building a deck and had not looked at boards for a few days. I immediately left the SLJB board after I saw several thousand "new" posts and came here. Should have come here first :)
SLJB makes "most number of trade leaders",lol. See bottom paragraph.
CybeRelease: (OTC PK: PHYH) Receives Short-Term Price Target of $.14
CybeRelease
8/30/2006 8:36:12 AM
WebWire Related Industries
• Banking/Financial Services
• Financial Markets
• OTC/SmallCap
(CybeRelease, August 30, 2006) - Lake Harmony - Shares of the upstart physician-based and community-focused healthcare organization developer and operator, Physicians Healthcare Management Group, Inc (OTC PK: PHYH), were issued an Investment Opinion this morning from Presage Partners LLC, a Florida-based consulting, research and advisory firm that also issues speculative trading ideas in Micro-Cap and Small-Cap public companies to the public.
Directly quoting an excerpt from the report, "Our discounted cash flow (DCF) and Net Present Value (NPV) calculations, based on interviews with the Company’s management about the prospects for growth as well as the company’s projected financial performance over the next 5 years suggest our conservative short-term "fair-value" target of $.14 per share is justifiable. Notwithstanding our conservative short-term "fair-value" calculation, under our second, and more aggressive, Long-Term "fair value" scenario, suggests that a share price of $1.13 is justifiable."
To read the complete release, go to http://www.CybeRelease.com/phyh83006.htm
For more information on Physicians Healthcare Management Group, Inc., go to http://www.phyhealth.com
CybeRelease OTCBB Share Volume Leaders are Nexia Holdings Inc. (OTC BB: NEXH), Gateway Distributors, Ltd. (OTC BB: GWDB), Universal Express Inc. (OTC BB: USXP), Collectible Concepts Group, Inc. (OTC BB: CCGI.OB).
CybeRelease OTCBB Most Number of Trades are True North Energy Corporation (OTC BB: TNEN), Solomon Technologies, Inc. (OTC BB: SOLM), Conversion Solutions Holdings Corp (OTC BB: CSHD), Advanced Cell Technology, Inc. (OTC BB: ACTC).
CybeRelease Pink Sheets Share Volume Leaders are Imperia Entertainment (Pink Sheets: IPRE), AuGRID Corporation (Pink Sheets: AUGC), Blackout Media Corp (Pink Sheets: BKMP), FSBO Media Holdings, Inc. (Pink Sheets: FSMH.
CybeRelease Pink Sheets Most Number of Trades Leaders are Gaming Transactions Inc. (Pink Sheets: GGTS), L International Computers Inc. (Pink Sheets: LITL), eCarfly, Inc. (Pink Sheets: ECFL), Sulja Bros. Building Supplies, Ltd. (Pink Sheets: SLJB
NanoViricides, Inc. H5N1 Bird Flu Studies Presented at Novel Vaccines Conference; Three Bird Flu and Influenza Drugs Now in the Pipeline
By BusinessWire
Last Update: 8/29/2006 7:30:35 AM Data provided by
WEST HAVEN, Conn., Aug 29, 2006 (BUSINESS WIRE) -- NanoViricides, Inc. (Pink Sheets: NNVC) revealed new details of its work in the fight against Bird Flu at a gathering of cutting-edge researchers at the Cambridge Healthcare Institute's conference "Novel Vaccines: Bridging Research, Development and Production" in Boston last week.
"Nanoviricides, Inc. intends to define the next plateau of antiviral therapeutics," Dr. Anil Diwan, the Company's President, told scientists, explaining the Company's work combating H5N1 (avian influenza), the common human flu, as well as the Company's approach against other viral threats such as Hepatitis C and HIV.
"We now have three nanoviricides(TM), all effective against H5N1, entering further detailed studies with the goal of filing INDs," he added, explaining, "the data were fully consistent with our design expectations." Thus, AviFluCide-I(TM) is designed to be specific to H5N1, and FluCide-I(TM) is designed to work against all influenzas, whereas FluCide-HP(TM) is designed to work against the entire highly pathogenic influenza subgroup that poses continuously re-emerging and changing pandemics threats.
Highlighting new information gleaned from H5N1 preclinical studies recently completed in Vietnam, Dr. Diwan showed that many nanoviricide(TM) candidates were effective at as low as 5-nanomolar concentration levels in cell culture experiments. Typically, an early developmental drug that proves effective at concentrations less than 500 nanomolars is considered a strong candidate for FDA approval as an "Investigational New Drug (IND)" applicant.
A nanoviricide(TM) is made by attaching a ligand (targeting molecule) to a core nanomaterial that forms the "viricidal engine" of the assembly. The ligand directs the viricidal engine to find and bind to a specific type of virus. The viricidal engine is designed to be capable of neutralizing most enveloped viruses. Dr. Diwan showed that attaching a ligand to the viricidal engine leads to as much as 50X (5,000%) greater effectiveness compared to the ligand itself. Scientists attending the conference felt that this could have significant implications for developing greatly improved drugs by resurrecting compounds that may have proven marginal or failed earlier.
Bird flu fatalities in 2006 have already topped those in 2005, with Indonesia reporting 60 human cases, and 1 in 5 fatalities. The Centers for Disease Control report that common influenza alone kills 36,000 people in the USA and causes 200,000 people to be hospitalized. "The influenzas represent a multi-billion dollar market if effective drugs can be created even if no epidemics occur," said Eugene Seymour, MD, MPH, the Company CEO.
"We believe NanoViricides, Inc. has the best current drugs in development against bird flu (H5N1), high path influenza, and common influenza," said Dr. Diwan, while acknowledging that "additional studies are needed to further characterize these drugs."
About NanoViricides - http://www.nanoviricides.com
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. A NanoViricide(TM) is a specially designed, flexible, nanomaterial that contains an encapsulated active pharmaceutical ingredient and targets it to a specific type of virus, like a guided missile. NanoViricide drugs are designed to block and dismantle the virus particles before they can infect a cell, thereby controlling viremia. This is a completely novel approach that is proving to be superior to existing approaches. This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors including the success of the Company's research and development strategy, the availability of adequate financing, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process.
SOURCE: NanoViricides, Inc.
NanoViricides, Inc. H5N1 Bird Flu Studies Presented at Novel Vaccines Conference; Three Bird Flu and Influenza Drugs Now in the Pipeline
By BusinessWire
Last Update: 8/29/2006 7:30:35 AM Data provided by
WEST HAVEN, Conn., Aug 29, 2006 (BUSINESS WIRE) -- NanoViricides, Inc. (Pink Sheets: NNVC) revealed new details of its work in the fight against Bird Flu at a gathering of cutting-edge researchers at the Cambridge Healthcare Institute's conference "Novel Vaccines: Bridging Research, Development and Production" in Boston last week.
"Nanoviricides, Inc. intends to define the next plateau of antiviral therapeutics," Dr. Anil Diwan, the Company's President, told scientists, explaining the Company's work combating H5N1 (avian influenza), the common human flu, as well as the Company's approach against other viral threats such as Hepatitis C and HIV.
"We now have three nanoviricides(TM), all effective against H5N1, entering further detailed studies with the goal of filing INDs," he added, explaining, "the data were fully consistent with our design expectations." Thus, AviFluCide-I(TM) is designed to be specific to H5N1, and FluCide-I(TM) is designed to work against all influenzas, whereas FluCide-HP(TM) is designed to work against the entire highly pathogenic influenza subgroup that poses continuously re-emerging and changing pandemics threats.
Highlighting new information gleaned from H5N1 preclinical studies recently completed in Vietnam, Dr. Diwan showed that many nanoviricide(TM) candidates were effective at as low as 5-nanomolar concentration levels in cell culture experiments. Typically, an early developmental drug that proves effective at concentrations less than 500 nanomolars is considered a strong candidate for FDA approval as an "Investigational New Drug (IND)" applicant.
A nanoviricide(TM) is made by attaching a ligand (targeting molecule) to a core nanomaterial that forms the "viricidal engine" of the assembly. The ligand directs the viricidal engine to find and bind to a specific type of virus. The viricidal engine is designed to be capable of neutralizing most enveloped viruses. Dr. Diwan showed that attaching a ligand to the viricidal engine leads to as much as 50X (5,000%) greater effectiveness compared to the ligand itself. Scientists attending the conference felt that this could have significant implications for developing greatly improved drugs by resurrecting compounds that may have proven marginal or failed earlier.
Bird flu fatalities in 2006 have already topped those in 2005, with Indonesia reporting 60 human cases, and 1 in 5 fatalities. The Centers for Disease Control report that common influenza alone kills 36,000 people in the USA and causes 200,000 people to be hospitalized. "The influenzas represent a multi-billion dollar market if effective drugs can be created even if no epidemics occur," said Eugene Seymour, MD, MPH, the Company CEO.
"We believe NanoViricides, Inc. has the best current drugs in development against bird flu (H5N1), high path influenza, and common influenza," said Dr. Diwan, while acknowledging that "additional studies are needed to further characterize these drugs."
About NanoViricides - http://www.nanoviricides.com
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. A NanoViricide(TM) is a specially designed, flexible, nanomaterial that contains an encapsulated active pharmaceutical ingredient and targets it to a specific type of virus, like a guided missile. NanoViricide drugs are designed to block and dismantle the virus particles before they can infect a cell, thereby controlling viremia. This is a completely novel approach that is proving to be superior to existing approaches. This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors including the success of the Company's research and development strategy, the availability of adequate financing, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process.
SOURCE: NanoViricides, Inc.
NanoViricides, Inc. H5N1 Bird Flu Studies Presented at Novel Vaccines Conference; Three Bird Flu and Influenza Drugs Now in the Pipeline
By BusinessWire
Last Update: 8/29/2006 7:30:35 AM Data provided by
WEST HAVEN, Conn., Aug 29, 2006 (BUSINESS WIRE) -- NanoViricides, Inc. (Pink Sheets: NNVC) revealed new details of its work in the fight against Bird Flu at a gathering of cutting-edge researchers at the Cambridge Healthcare Institute's conference "Novel Vaccines: Bridging Research, Development and Production" in Boston last week.
"Nanoviricides, Inc. intends to define the next plateau of antiviral therapeutics," Dr. Anil Diwan, the Company's President, told scientists, explaining the Company's work combating H5N1 (avian influenza), the common human flu, as well as the Company's approach against other viral threats such as Hepatitis C and HIV.
"We now have three nanoviricides(TM), all effective against H5N1, entering further detailed studies with the goal of filing INDs," he added, explaining, "the data were fully consistent with our design expectations." Thus, AviFluCide-I(TM) is designed to be specific to H5N1, and FluCide-I(TM) is designed to work against all influenzas, whereas FluCide-HP(TM) is designed to work against the entire highly pathogenic influenza subgroup that poses continuously re-emerging and changing pandemics threats.
Highlighting new information gleaned from H5N1 preclinical studies recently completed in Vietnam, Dr. Diwan showed that many nanoviricide(TM) candidates were effective at as low as 5-nanomolar concentration levels in cell culture experiments. Typically, an early developmental drug that proves effective at concentrations less than 500 nanomolars is considered a strong candidate for FDA approval as an "Investigational New Drug (IND)" applicant.
A nanoviricide(TM) is made by attaching a ligand (targeting molecule) to a core nanomaterial that forms the "viricidal engine" of the assembly. The ligand directs the viricidal engine to find and bind to a specific type of virus. The viricidal engine is designed to be capable of neutralizing most enveloped viruses. Dr. Diwan showed that attaching a ligand to the viricidal engine leads to as much as 50X (5,000%) greater effectiveness compared to the ligand itself. Scientists attending the conference felt that this could have significant implications for developing greatly improved drugs by resurrecting compounds that may have proven marginal or failed earlier.
Bird flu fatalities in 2006 have already topped those in 2005, with Indonesia reporting 60 human cases, and 1 in 5 fatalities. The Centers for Disease Control report that common influenza alone kills 36,000 people in the USA and causes 200,000 people to be hospitalized. "The influenzas represent a multi-billion dollar market if effective drugs can be created even if no epidemics occur," said Eugene Seymour, MD, MPH, the Company CEO.
"We believe NanoViricides, Inc. has the best current drugs in development against bird flu (H5N1), high path influenza, and common influenza," said Dr. Diwan, while acknowledging that "additional studies are needed to further characterize these drugs."
About NanoViricides - http://www.nanoviricides.com
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for viral therapy. A NanoViricide(TM) is a specially designed, flexible, nanomaterial that contains an encapsulated active pharmaceutical ingredient and targets it to a specific type of virus, like a guided missile. NanoViricide drugs are designed to block and dismantle the virus particles before they can infect a cell, thereby controlling viremia. This is a completely novel approach that is proving to be superior to existing approaches. This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Forward-looking statements involve risks and uncertainties. Actual events could differ materially and substantially from those projected herein and depend on a number of factors including the success of the Company's research and development strategy, the availability of adequate financing, the successful and timely completion of clinical studies and the uncertainties related to the regulatory process.
SOURCE: NanoViricides, Inc.
Thanks digital, hope you get to post it.
Welcome SPIN, I thought your name seemed familiar,lol. I'm the poster who reposted your google find on the SLJB board yesterday and a couple of jerks accused me of altering it and being a basher. Someone then accused you of altering it. I TOS'd them and Rager took action. I said I was through with the board after that but went back today and thanked Rager and other mods.
Brent calmed me down and told me to not take it so seriously (just like my wife does) so this is my last post about that.
You have come to a good board for honest DD without a slap in the jaw if you ask an honest question or post honest DD pro or con,imo. After all, we need both to make rational decisions.